Medicines & supplements – Current GIS Alerts 2026
Found 735 alerts in the Medicines & supplements category. Check batch numbers, shops, and hazard information.
Common hazards in this category
All recalled products
FOSIDAL O SMAKU POMARAŃCZOWYM
An unfavourable benefit-risk ratio was identified for the active substance fenspiride, associated with a potential, real and highly probable risk to patients’ health or life, requiring immediate action by supervisory authorities. Potential effects: serious adverse reactions, risk to health or life, possible cardiac complications.
FOSIDAL O SMAKU MALINOWYM
Unfavourable benefit–risk balance for the active substance fenspiride, which may pose a real and highly probable risk to patients’ health or life, even without damage having occurred so far. Potential effects: serious adverse reactions, complications, life‑threatening events.
EURESPAL
Unfavourable benefit-risk ratio of the active substance fenspiride based on non-clinical studies; an urgent EU procedure was initiated due to a public health concern. Potential effects: serious adverse reactions, threat to health or life.
EURESPAL
An unfavorable benefit-risk ratio for the active substance fenspiride was identified based on non-clinical studies; an EU review procedure was initiated. Potential effects: deterioration of health, serious adverse reactions.
EURESPAL
Unfavourable benefit-risk balance for the active substance fenspiride, posing a public health hazard. Potential effects: serious adverse reactions, threat to health or life.
EURESPAL
Unfavorable benefit-risk ratio of the active substance fenspiride; an urgent EU reassessment procedure was initiated. Potential effects: adverse reactions, health complications.
EURESPAL
Unfavorable benefit-risk ratio of the active substance fenspiride; an EU re-evaluation procedure was initiated. Potential effects: serious adverse reactions, risk to health or life.
EURESPAL
Unfavourable benefit–risk balance of the active substance fenspiride, which may pose a public health risk. Potential effects: deterioration of health, complications, life‑threatening risk.
EURESPAL
Unfavourable benefit-risk balance for the active substance fenspiride, which may pose a public health risk and requires reassessment. Potential effects: serious adverse reactions, risk to health or life.
EURESPAL
Unfavourable benefit-risk ratio for the active substance fenspiride; potential public health hazard. Potential effects: serious adverse reactions, risk to health or life.
EURESPAL
Unfavourable benefit–risk balance of the active substance fenspiride indicated by non-clinical studies. Potential effects: serious adverse reactions, threat to health or life.
FENSPOGAL
Unfavourable benefit-risk ratio for the active substance fenspiride, causing a potential, real and highly probable risk to patients' health or life, justifying immediate suspension and prohibition of placing the product on the market. Potential effects: serious adverse reactions, complications, life‑threatening events.
FOSIDAL O SMAKU POMARAŃCZOWYM
An unfavorable benefit-risk ratio was identified for the active substance fenspiride, posing a potential threat to patients’ health or life, justifying immediate suspension of marketing and a temporary ban on placing the product on the market. Potential effects: serious adverse reactions, threat to health or life.
EUREFIN
Unfavorable benefit-risk ratio of the active substance fenspiride, leading to withdrawal of the reference product and initiation of an EU review. Potential effects: serious adverse reactions, risk to health or life.
PULNEO O SMAKU COLI
An unfavourable benefit-risk balance was identified for the active substance fenspiride, which may represent a real and highly probable risk to patients’ health or life. Potential effects: serious adverse reactions, risk to health or life.
PULNEO O SMAKU COLI
An unfavourable benefit-risk ratio for the active substance fenspiride, potentially posing a risk to patients’ health or life, with the probability of harm to a person considered significant. Potential effects: serious adverse reactions, complications, threat to health or life.
EURESPAL
Unfavourable benefit–risk balance for the active substance fenspiride; potential public health risk. The French agency (ANSM) initiated an urgent EU review. Potential effects: risk to health or life.
EURESPAL
Unfavourable benefit-risk ratio for the active substance fenspiride; the French agency ANSM initiated an urgent EU re-evaluation procedure. Potential effects: deterioration of health, risk of complications.
EUREFIN
Unfavourable benefit–risk ratio for the active substance fenspiride identified from non-clinical studies; an EU review procedure initiated. Potential effects: serious adverse reactions, threat to health or life.
ELOFEN
What to do if you bought a recalled product?
If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.